Imperial College London


Faculty of MedicineDepartment of Surgery & Cancer

Honorary Lecturer



+44 (0)20 7594 2823silvia.ottaviani




ICTEM buildingHammersmith Campus




Ongoing Projects

  • The role of TGF-β-induced microRNAs in pancreatic cancer
  • Use of nanoparticles for delivery of anti-miRNAs in pancreatic cancer
  • CRISPR/Cas9 screening to identify functional microRNA targets
  • MicroRNAs as biomarkers for COVID-19 disease
  • Investigating tumour heterogeneity using single-cell RNA sequencing

Reviewer for Following Journals

show research

Guest Lectures

Baricitinib: computer to FDA approval in 10 months, Imperial College London, Drug Discovery Symposium, 2021

miRNAs in pancreatic cancer: from discovery to function, NanoString, Webinar, 2020

The role of non-coding RNAs regulated by TGF-β in controlling pancreatic cancer progression, Precision CRISPR EU, London, 2018

Investigating the role of microRNAs in pancreatic cancer progression, ThermoFisher Scientific, Webinar, 2018

Research Student Supervision

Chakravarthy,Y, Inhibition of microRNAs synergistically inhibits tumour growth in KPC mice derived CHX-Luc cell line

Fan,H, Developing an high throughut genome-wide screen to identify functional microRNAs targets that promote stemness in pancreatic cancer using CRISPR-Cas9

Psujek,M, The evaluation of miR-100 and/or miR-125b inhibition as a novel therapeutic approach for pancreatic cancer,